US 12,115,360 B2
Hybrid drug delivery devices with grip portion
Margaux Frances Boyaval, Newbury Park, CA (US); Brian Stonecipher, Newbury Park, CA (US); Avon Kuo, San Jose, CA (US); James Chan, San Marino, CA (US); and Lisa Nugent, Malibu, CA (US)
Assigned to AMGEN INC., Thousand Oaks, CA (US)
Appl. No. 17/256,243
Filed by AMGEN INC., Thousand Oaks, CA (US)
PCT Filed Jul. 22, 2019, PCT No. PCT/US2019/042749
§ 371(c)(1), (2) Date Dec. 28, 2020,
PCT Pub. No. WO2020/023336, PCT Pub. Date Jan. 30, 2020.
Claims priority of provisional application 62/702,813, filed on Jul. 24, 2018.
Prior Publication US 2021/0228815 A1, Jul. 29, 2021
Int. Cl. A61M 5/32 (2006.01); A61M 5/20 (2006.01); A61M 5/31 (2006.01)
CPC A61M 5/3204 (2013.01) [A61M 5/20 (2013.01); A61M 2005/2013 (2013.01); A61M 2005/208 (2013.01); A61M 2005/3107 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A drug delivery device comprising:
a housing having a generally vertical orientation along a longitudinal axis;
drug delivery components disposed within the housing such that at least a plurality of the drug delivery components are disposed in a generally stacked relation along the longitudinal axis, the drug delivery components including a needle;
a generally planar skin contact surface extending around the needle;
a retention portion of the skin contact surface configured to grip skin of a user; and
a needle guard coupled to the housing and movable between a guard position and a use position, the needle guard including a needle opening extending therethrough such that moving the needle guard to the use position causes the needle to extend through the needle opening,
wherein the needle guard comprises a bottom wall defining at least a portion of the skin contact surface,
wherein the bottom wall has a dimension extending thereacross that is between about one half and a full height of the housing along the longitudinal axis, such that the housing is stable in a vertical orientation with the housing resting on a horizontal surface.